These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Tyrphostin AG490 agent modestly but significantly prevents onset of type 1 in NOD mouse; implication of immunologic and metabolic effects of a Jak-Stat pathway inhibitor. Davoodi-Semiromi A, Hassanzadeh A, Wasserfall CH, Droney A, Atkinson M. J Clin Immunol; 2012 Oct 27; 32(5):1038-47. PubMed ID: 22661285 [Abstract] [Full Text] [Related]
10. Suppression of experimental autoimmune encephalomyelitis by tyrphostin AG-556. Brenner T, Poradosu E, Soffer D, Sicsic C, Gazit A, Levitzki A. Exp Neurol; 1998 Dec 27; 154(2):489-98. PubMed ID: 9878184 [Abstract] [Full Text] [Related]
11. Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes. Davoodi-Semiromi A, Wasserfall CH, Hassanzadeh A, Cooper-DeHoff RM, Wabitsch M, Atkinson M. Immunogenetics; 2013 Jan 27; 65(1):83-90. PubMed ID: 23081744 [Abstract] [Full Text] [Related]
12. COX-2 inhibitors modulate IL-12 signaling through JAK-STAT pathway leading to Th1 response in experimental allergic encephalomyelitis. Muthian G, Raikwar HP, Johnson C, Rajasingh J, Kalgutkar A, Marnett LJ, Bright JJ. J Clin Immunol; 2006 Jan 27; 26(1):73-85. PubMed ID: 16418805 [Abstract] [Full Text] [Related]
13. Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way. Berghmans N, Dillen C, Heremans H. J Neuroimmunol; 2006 Jul 27; 176(1-2):63-75. PubMed ID: 16764944 [Abstract] [Full Text] [Related]
14. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression. Imler TJ, Petro TM. Int Immunopharmacol; 2009 Jan 27; 9(1):134-43. PubMed ID: 19022403 [Abstract] [Full Text] [Related]
15. Combinatorial approach to identification of tyrphostin inhibitors of cytokine signaling. Gu L, Zhuang H, Safina B, Xiao XY, Bradford WW, Rich BE. Bioorg Med Chem; 2005 Jul 01; 13(13):4269-78. PubMed ID: 15869881 [Abstract] [Full Text] [Related]
17. Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells. Granato M, Chiozzi B, Filardi MR, Lotti LV, Di Renzo L, Faggioni A, Cirone M. Cancer Lett; 2015 Oct 01; 366(2):191-7. PubMed ID: 26184999 [Abstract] [Full Text] [Related]
18. Tyrosine kinases are required for interferon-gamma-stimulated proliferation of Trypanosoma brucei brucei. Mustafa E, Bakhiet M, Jaster R, Bittorf T, Mix E, Olsson T. J Infect Dis; 1997 Mar 01; 175(3):669-73. PubMed ID: 9041340 [Abstract] [Full Text] [Related]
19. Tyrphostin A9 protects axons in experimental autoimmune encephalomyelitis through activation of ERKs. Dai X, Wang Y, Li Y, Zhong Y, Pei M, Long J, Dong X, Chen YL, Wang Q, Wang G, Gold BG, Vandenbark AA, Neve KA, Offner H, Wang C. Life Sci; 2022 Apr 01; 294():120383. PubMed ID: 35143827 [Abstract] [Full Text] [Related]
20. The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditis. George J, Barshack I, Goldberg I, Keren P, Gazit A, Levitzki A, Keren G, Roth A. Exp Mol Pathol; 2004 Jun 01; 76(3):234-41. PubMed ID: 15126106 [Abstract] [Full Text] [Related] Page: [Next] [New Search]